Zydus gets USFDA final nod for Baclofen Tablets

Ahmedabad: Zydus Cadila has received final approval from the USFDA to market Baclofen Tablets, 5 mg.

Baclofen is used to treat muscle spasms caused by certain conditions such as multiple sclerosis, spinal cord injury/disease. It works by helping to relax the muscles. It will be manufactured at the group's formulations manufacturing facility at Baddi.

The group now has 288 approvals and has so far filed over 386 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Cadila is an innovative, global pharmaceutical company headquartered in Ahmedabad, India. The company discovers, develops, manufactures and markets a broad range of healthcare therapies.

The group has manufacturing sites and research facilities spread across five states of Gujarat, Maharashtra, Goa, Himachal Pradesh and Sikkim in India and in the US and Brazil.

Read also: Zydus gets USFDA final approval for Erlotinib Tablets